Your browser doesn't support javascript.
loading
Impact of an Intervention Program on Clostridioides difficile Infections: Comparison of 2 Hospital Cohorts.
Kamel, Sara; Corbacho-Loarte, María Dolores; Escudero-Sánchez, Rosa; Halperin, Ana; Llorente, Sergio; Quevedo, Sara María; Suárez-Carantoña, Cecilia; Del Campo, Laura; Hernández, María Soledad; Guillen, Santiago Moreno; Cobo, Javier.
  • Kamel S; Internal Medicine Department, Hospital Universitario Severo Ochoa, Madrid, Spain.
  • Corbacho-Loarte MD; Infectious Diseases Department, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain.
  • Escudero-Sánchez R; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
  • Halperin A; Infectious Diseases Department, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain.
  • Llorente S; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
  • Quevedo SM; Microbiology Department, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain.
  • Suárez-Carantoña C; Internal Medicine Department, Hospital Universitario Severo Ochoa, Madrid, Spain.
  • Del Campo L; Microbiology Department, Hospital Universitario Severo Ochoa, IRYCIS, Madrid, Spain.
  • Hernández MS; IInternal Medicine Department, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain.
  • Guillen SM; Medicine Department, Alcalá University, Madrid, Spain.
  • Cobo J; Biostatistics Department, CIBERESP, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain.
Open Forum Infect Dis ; 11(7): ofae390, 2024 Jul.
Article en En | MEDLINE | ID: mdl-39050227
ABSTRACT

Background:

Clostridioides difficile infection (CDI) occurs in various contexts and care settings and is managed by multiple specialists who are not experts in its management. While there are many initiatives to improve the diagnosis and avoid overdiagnosis, there is less focus on the overall management of the infection.

Methods:

We studied a cohort of patients with a positive test result for toxigenic C difficile in 2 hospitals. Hospital A has a program that provides advice from an infectious disease specialist (IDS) and promotes continuity of care by providing a phone number to contact the IDS. Hospital B does not have any specific CDI program. The evaluation assessed the proportion of patients not treated (carriers or self-limited disease), adherence to Infectious Diseases Society of America guidelines, access to novel therapies, recurrence and mortality rates, and readmission and emergency department visits due to CDI. We assessed the program's effectiveness through a logistic regression model adjusted for covariates chosen by clinical criteria.

Results:

Hospital A avoided more unnecessary treatments (19.3% vs 11.5%), provided access to novel therapies more frequently (35.3% vs 13%), and adhered more closely to current guidelines (95.8% vs 71.3%). Although the mortality and recurrence rates did not differ, the absence of an intervention program was associated with greater odds of admission due to recurrence (odds ratio, 4.19; P = .037) and more visits to the emergency department due to CDI (odds ratio, 8.74; P = .001).

Conclusions:

Implementation of a CDI intervention program based on recommendations from IDSs and improved access to specialized care during the follow-up is associated with enhanced quality of CDI management and potential reductions in hospital resource utilization.
Palabras clave